BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10487799)

  • 1. Increasing the impact of cardiological treatments. How best to reduce deaths.
    Capewell S; Pell JP; Morrison C; McMurray J
    Eur Heart J; 1999 Oct; 20(19):1386-92. PubMed ID: 10487799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
    Capewell S; Morrison CE; McMurray JJ
    Heart; 1999 Apr; 81(4):380-6. PubMed ID: 10092564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.
    Critchley JA; Capewell S
    J Epidemiol Community Health; 2003 Apr; 57(4):243-7. PubMed ID: 12646537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data.
    Hotchkiss JW; Davies CA; Dundas R; Hawkins N; Jhund PS; Scholes S; Bajekal M; O'Flaherty M; Critchley J; Leyland AH; Capewell S
    BMJ; 2014 Feb; 348():g1088. PubMed ID: 24503058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study.
    Bandosz P; O'Flaherty M; Drygas W; Rutkowski M; Koziarek J; Wyrzykowski B; Bennett K; Zdrojewski T; Capewell S
    BMJ; 2012 Jan; 344():d8136. PubMed ID: 22279114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential reductions in United States coronary heart disease mortality by treating more patients.
    Capewell S; O'Flaherty M; Ford ES; Critchley JA
    Am J Cardiol; 2009 Jun; 103(12):1703-9. PubMed ID: 19539079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality.
    Wijeysundera HC; Mitsakakis N; Witteman W; Paulden M; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Can J Cardiol; 2011; 27(6):756-62. PubMed ID: 21920697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000.
    Unal B; Critchley JA; Fidan D; Capewell S
    Am J Public Health; 2005 Jan; 95(1):103-8. PubMed ID: 15623868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality.
    Unal B; Critchley JA; Capewell S
    J Clin Epidemiol; 2005 Jul; 58(7):733-40. PubMed ID: 15939226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?
    Critchley JA; Capewell S; Unal B
    J Clin Epidemiol; 2003 Jun; 56(6):583-90. PubMed ID: 12873654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains.
    Björck L; Capewell S; Bennett K; Lappas G; Rosengren A
    J Intern Med; 2011 Apr; 269(4):452-67. PubMed ID: 21205025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.
    Laatikainen T; Critchley J; Vartiainen E; Salomaa V; Ketonen M; Capewell S
    Am J Epidemiol; 2005 Oct; 162(8):764-73. PubMed ID: 16150890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle].
    Savonitto S; Klugmann S
    Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML; Grobbee DE
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.